These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20404124)

  • 1. Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.
    Diniz Lde F; Caldas IS; Guedes PM; Crepalde G; de Lana M; Carneiro CM; Talvani A; Urbina JA; Bahia MT
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2979-86. PubMed ID: 20404124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
    Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease.
    Urbina JA; Payares G; Sanoja C; Lira R; Romanha AJ
    Int J Antimicrob Agents; 2003 Jan; 21(1):27-38. PubMed ID: 12507835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection.
    Machado YA; Bahia MT; Caldas IS; Mazzeti AL; Novaes RD; Vilas Boas BR; Santos LJS; Martins-Filho OA; Marques MJ; Diniz LF
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
    Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease.
    Spósito PÁ; Mazzeti AL; de Castro KCMP; Mendes PF; Urbina JA; Bahia MT; Mosqueira VCF
    Exp Parasitol; 2021 Sep; 228():108142. PubMed ID: 34375652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
    Torrico F; Gascon J; Ortiz L; Alonso-Vega C; Pinazo MJ; Schijman A; Almeida IC; Alves F; Strub-Wourgaft N; Ribeiro I;
    Lancet Infect Dis; 2018 Apr; 18(4):419-430. PubMed ID: 29352704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
    de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM
    Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ravuconazole self-emulsifying delivery system: in vitro activity against
    Spósito PÁ; Mazzeti AL; de Oliveira Faria C; Urbina JA; Pound-Lana G; Bahia MT; Mosqueira VF
    Int J Nanomedicine; 2017; 12():3785-3799. PubMed ID: 28553114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chagas cardiomyopathy: The potential effect of benznidazole treatment on diastolic dysfunction and cardiac damage in dogs chronically infected with Trypanosoma cruzi.
    Santos FM; Mazzeti AL; Caldas S; Gonçalves KR; Lima WG; Torres RM; Bahia MT
    Acta Trop; 2016 Sep; 161():44-54. PubMed ID: 27215760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
    Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.
    Urbina JA
    J Eukaryot Microbiol; 2015; 62(1):149-56. PubMed ID: 25284065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listen to what the animals say: a systematic review and meta-analysis of sterol 14-demethylase inhibitor efficacy for in vivo models of Trypanosoma cruzi infection.
    Bisio MMC; Jurado Medina LS; García-Bournissen F; Gulin JEN
    Parasitol Res; 2024 Jun; 123(6):248. PubMed ID: 38904688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
    Carneiro CM; Martins-Filho OA; Reis AB; Veloso VM; Araújo FM; Bahia MT; de Lana M; Machado-Coelho GL; Gazzinelli G; Correa-Oliveira R; Tafuri WL
    Acta Trop; 2007 Feb; 101(2):120-9. PubMed ID: 17296162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of experimental reinfection by Trypanosoma cruzi in dogs.
    Machado EM; Fernandes AJ; Murta SM; Vitor RW; Camilo DJ; Pinheiro SW; Lopes ER; Adad SJ; Romanha AJ; Pinto Dias JC
    Am J Trop Med Hyg; 2001 Dec; 65(6):958-65. PubMed ID: 11792006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.